Flumazenil (flumazepil, Anexate®, Lanexat®, Mazicon®, Romazicon®) occurs as benzodiazepine antagonist, used as an antidote in the treatment of benzodiazepine overdose. It reverses a results of benzodiazepines by competitive inhibition of benzodiazepine receptors.

A onset of action is in no time, astir a single to 2 transactions. A activity peak is six to ten transactions. Numerous benzodiazepines keep around yearn half-lives than flumazenil. So repetition drugs of flumazenil can be called upon to end repeated symptoms of overdosage once a initial dose of flumazenil wears off.

It was introduced inside 1987 by Hoffmann-La Roche under trade name Anexate.